Theriva Biologics (TOVX) Assets (2010 - 2026)
Theriva Biologics (TOVX) posted quarterly Assets of $38.2 million for Q1 2026, up 18.93% year-over-year from $32.2 million in Q1 2025, and little changed quarter-over-quarter from $38.2 million in Q4 2025.
Theriva Biologics (TOVX) Assets (2010 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Assets for 17 consecutive years, with $38.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 18.93% year-over-year to $38.2 million; the TTM figure through Mar 2026 stood at $38.2 million (up 18.93% YoY), while the FY2025 annual figure was $38.2 million, up 8.17% from the prior year.
- Assets steadied at $38.2 million in Q1 2026 per TOVX's latest filing, from $38.2 million in the prior quarter.
- Across five years, Assets topped out at $89.0 million in Q1 2022 and bottomed at $30.8 million in Q3 2025.
- Historically, Assets has averaged $53.6 million across 5 years, with a median of $48.7 million in 2024.
- Annual changes were most pronounced in 2024 — Assets slumped 35.98% — and 2026, when it climbed 18.93%.
- Theriva Biologics' Assets stood at $71.9 million in 2022, then fell by 23.16% to $55.2 million in 2023, then plunged by 35.98% to $35.4 million in 2024, then grew by 8.17% to $38.2 million in 2025, then climbed by 0.02% to $38.2 million in 2026.
- Business Quant data shows TOVX's Assets at $38.2 million in Q1 2026, $38.2 million in Q4 2025, and $30.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 19.82 Bn |
| 10 | Theriva Biologics | 10.92 Mn | 10.92 Mn | - | 34.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.86 Mn |
| Mar 31, 2026 | 38.25 Mn |
| Dec 31, 2025 | 38.24 Mn |
| Sep 30, 2025 | 30.84 Mn |
| Jun 30, 2025 | 35.83 Mn |
| Mar 31, 2025 | 32.16 Mn |
| Dec 31, 2024 | 35.35 Mn |
| Sep 30, 2024 | 40.11 Mn |
| Jun 30, 2024 | 42.39 Mn |
| Mar 31, 2024 | 48.73 Mn |
| Dec 31, 2023 | 55.22 Mn |
| Sep 30, 2023 | 61.55 Mn |
| Jun 30, 2023 | 65.45 Mn |
| Mar 31, 2023 | 67.89 Mn |
| Dec 31, 2022 | 71.86 Mn |
| Sep 30, 2022 | 77.11 Mn |
| Jun 30, 2022 | 80.64 Mn |
| Mar 31, 2022 | 89.00 Mn |
| Dec 31, 2021 | 70.37 Mn |
| Sep 30, 2021 | 75.12 Mn |